Back to Search
TU DINH DAN M.D.
M.D.
Radiation Oncology Physician
NPI: 1902192123IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
Q9981(TX)
Education
UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Class of 2011
Research & Publications (12)
[Spectral wavelength selection based on PLS projection analysis].
PMID 19445201·Guang Pu Xue Yu Guang Pu Fen Xi·2009
8-other
A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage.
PMID 19536069·J Cereb Blood Flow Metab·2009
7-preclinical
Work rehabilitation in Mainland China: striving for better services and research. Introduction.
PMID 18330046·Work·2008
8-other
The role of megsin, a serine protease inhibitor, in diabetic mesangial matrix accumulation.
PMID 18580857·Kidney Int·2008
7-preclinical
A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic rats.
PMID 18658044·Arterioscler Thromb Vasc Biol·2008
7-preclinical
Inhibition of advanced glycation end products (AGEs): an implicit goal in clinical medicine for the treatment of diabetic nephropathy?
PMID 18954918·Diabetes Res Clin Pract·2008
7-preclinical
Oxaliplatin-induced hypersensitivity reaction displaying marked elevation of immunoglobulin E.
PMID 18045783·J Oncol Pharm Pract·2007
5-case
Emerging drugs to replace current leaders in first-line therapy for breast cancer.
PMID 16939387·Expert Opin Emerg Drugs·2006
6-review
Potential involvement of gelatinases and their inhibitors in Mannheimia haemolytica pneumonia in cattle.
PMID 15271895·Infect Immun·2004
7-preclinical
[A case of rectal cancer with multiple liver metastases that responded dramatically to pharmacokinetic modulating chemotherapy/CPT-11 therapy].
PMID 12040684·Gan To Kagaku Ryoho·2002
5-case
The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis.
PMID 11776321·Thromb Haemost·2001
4-observational
In vitro and in vivo studies of AT-1362, a newly synthesized and orally active inhibitor of thrombin.
PMID 11053622·Thromb Res·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5323 HARRY HINES BLVD
DALLAS, TX 75390 - Phone
- (214) 645-8525
Quick Facts
- NPI
- 1902192123
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 15
- Publications
- 12
Are you this provider?
Claim Your Profile